Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribavirin for RSV in HSCT Patients
NCT01502072Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Dec 2011
- Primary completion
- Feb 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of ribavirin in respiratory syncytial virus infection (RSV), sponsored by University of Texas MD Anderson Cancer Center. Started Dec 2011; status: completed.
02
Drugs
ribavirin
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT01502072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01502072.